New Test Predicts Which Senolytic Drugs Will Work for Individual Patients
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
4695 articles
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
Comprehensive review compares natural compounds, synthetic drugs, and exercise for combating age-related bone loss, muscle weakness, and joint degeneration.
New study shows clearing senescent cells with Navitoclax improves heart function and reduces inflammation in heart failure with preserved ejection fraction.
Year-long wearable device study shows PAH patients experience worsening sleep stages and reduced daily steps compared to healthy controls.
Large Chinese study reveals gender and age differences in how sleep-disordered breathing affects metabolic health across 3,440 adults.
Canadian study of 1,322 adults with type 1 diabetes finds 47% have poor sleep, linked to depression, weight, and lifestyle factors.
Study of 1,252 hypertensive patients reveals frequent nighttime urination significantly elevates blood pressure during sleep.
Review examines immunosuppressive drugs like cyclosporine and tacrolimus, highlighting new applications and safety management strategies.
Updated AHA/ACC guidelines maintain 130/80 mmHg threshold for diabetes patients, emphasizing earlier intervention to prevent cardiovascular complications.
Japanese Society of Hypertension unveils comprehensive program targeting morning hypertension, which affects 70% of patients despite treatment.
Comprehensive review reveals hexokinase method as the most precise technique for glucose testing in clinical laboratories.
NAD+ precursor supplementation restored fertility markers and improved embryo development in diabetes-induced reproductive dysfunction.